Ernexa Therapeutics (ERNA) Return on Sales [ROS] (2010 - 2026)
Ernexa Therapeutics (ERNA) recorded Return on Sales [ROS] of -14194.74% in Q4 2024, down 2429.43 percentage points from -11765.31% a year earlier and down 13730.88 percentage points from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
For FY2024, Ernexa Therapeutics reported Return on Sales [ROS] of -2612.33%, up 18522.67 percentage points from FY2023.
- Annual Return on Sales [ROS] has a five-year change of -2603.44 percentage points (FY2019 to FY2024).
- Across earlier years, Return on Sales [ROS] came in at -21135.00% in FY2023 and -124.97% in FY2020 (-116.07 pp).
- The Q4 2024 figure is the lowest quarterly Return on Sales [ROS] in data going back to Q2 2010.
- On a year-over-year basis, Return on Sales [ROS] rose in 1 of the last five quarters, with an average year-over-year change of -4448.39 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 10330.26 percentage points in Q3 2024, against a drop of 10512.78 percentage points in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -463.86% (Q3 2024), -10491.49% (Q2 2024) and -12312.77% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 28.37% |
| 10 | Ernexa Therapeutics | 2.43 Mn | -16.73 Mn | - | -7,461.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7,461.82% |
| Mar 31, 2026 | -12,704.55% |
| Sep 30, 2025 | -6,429.03% |
| Jun 30, 2025 | -1,993.54% |
| Mar 31, 2025 | -54,600.00% |
| Dec 31, 2024 | -14,194.74% |
| Sep 30, 2024 | -463.86% |
| Jun 30, 2024 | -10,491.49% |
| Mar 31, 2024 | -12,312.77% |
| Dec 31, 2023 | -11,765.31% |
| Sep 30, 2023 | -10,794.12% |
| Jun 30, 2023 | -18,954.17% |
| Mar 31, 2023 | -2,743.57% |
| Dec 31, 2022 | -1,252.53% |
| Sep 30, 2022 | -733.29% |
| Dec 31, 2020 | -187.80% |
| Sep 30, 2020 | -135.92% |
| Mar 31, 2020 | -42.38% |
| Dec 31, 2019 | -23.74% |
| Sep 30, 2019 | -6.90% |
API Access
Ernexa Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();